Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Microscopic Polyangiitis: early-phase trial registry

2 of 5 indexed Microscopic Polyangiitis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Microscopic Polyangiitis: 5 US clinical trials tracked, 2 recruiting.

Microscopic Polyangiitis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pennsylvania, running 3 of these trials.

Enrollment posture brief

Registry condition microscopic-polyangiitis

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 3

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Microscopic Polyangiitis (th…40%
Open-enrollment share among volume-matched conditions near Microscopic Polyangiitis

Microscopic Polyangiitis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Microscopic Polyangiitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Microscopic Polyangiitis is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Microscopic Polyangiitis research.

    University of Pennsylvania accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Microscopic Polyangiitis enrolment sits around 1,000 participants.

    Median target enrolment is 1,000 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Microscopic Polyangiitis research leans observational.

    1 interventional and 4 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Microscopic Polyangiitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

SC291 Biological
1 trials

US sites by state

Facility locations filed on Microscopic Polyangiitis trials. A trial with sites in several states counts in each.

Utah 3 trials
Pennsylvania 3 trials
Ohio 3 trials
Massachusetts 3 trials
Minnesota 2 trials
Washington 1 trials
New York 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Microscopic Polyangiitis page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Microscopic Polyangiitis condition card totals 5 registered trials; most-linked intervention SC291; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.